mBio · 2021 · 36 citations · 52 references
Life SciencesImmunologyMicrobiologyHost-pathogen InteractionsImmunology Of Infectious DiseasesInnate ImmunityBacterial InfectionsImmunopathology Of Infectious DiseasesInflammation In Infectious DiseaseInnate Immune Signaling PathwaysMacrophage BiologyPulmonary TuberculosisLung DiseasesMacrophage ImmunomodulationMacrophage Interferon ResponsesMacrophage Survival SignalingMycobacterial DiseaseMycobacterium Tuberculosis InfectionNon-tuberculous Mycobacterial InfectionsNontuberculous Mycobacterial Infections
The prevalence of lung diseases caused by nontuberculous mycobacteria, such as Mycobacterium avium, is increasing in countries where tuberculosis is not endemic, most likely because of an aging population that is immunocompromised from underlying disease or immunosuppressive therapy. Our study contributes to the understanding of mycobacterial survival and killing in human macrophages and, more broadly, to the impact of immunometabolism during infection. We show evidence of an antimicrobial program in human primary macrophages where activation of the transcription factor IRF1 and expression of the mitochondrial enzyme IRG1 restrict the intracellular growth of M. avium, possibly by directed delivery of itaconate to M. avium phagosomes. The study also sheds light on why patients on immunosuppressive therapy are more susceptible to mycobacterial infections, since TNF-α and IL-6 contribute to driving the described antimycobacterial program.
52
Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Evanna L. Mills, Dylan G. Ryan, Hiran A. Prag et al. · Nature · 2018 · 1.8K citations
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS
A. Phillip West, Igor E. Brodsky, Christoph Rahner et al. · Nature · 2011 · 1.6K citations · Full text